Ezose Sciences, Inc. Aligns to Add Diagnostics Capabilities to Its Core Biomarker Discovery Programs

Published: Dec 06, 2011

PINE BROOK, N.J.--(BUSINESS WIRE)--Ezose Sciences Inc., a leading glycomics research company, announced today that it has aligned its business with the Diagnostics Division of Shionogi & Co., Ltd., an established leader in diagnostics development and commercialization. As part of this new alignment, Kiyoshi Nagata, Ph.D., has been named Chairman and Chief Executive Officer of Ezose.

Back to news